Pangenomic Health Statistics

Total Valuation

Pangenomic Health has a market cap or net worth of CAD 1.34 million. The enterprise value is 1.33 million.

Market Cap	1.34M
Enterprise Value	1.33M

Important Dates

The next estimated earnings date is Friday, November 29, 2024.

Earnings Date	Nov 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Pangenomic Health has 6.40 million shares outstanding. The number of shares has increased by 124.44% in one year.

Current Share Class	n/a
Shares Outstanding	6.40M
Shares Change (YoY)	+124.44%
Shares Change (QoQ)	+166.58%
Owned by Insiders (%)	2.14%
Owned by Institutions (%)	n/a
Float	6.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.36
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.04

Current Ratio	0.04
Quick Ratio	0.04
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-19.86

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-578.67%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.33% in the last 52 weeks. The beta is -1.38, so Pangenomic Health's price volatility has been lower than the market average.

Beta (5Y)	-1.38
52-Week Price Change	-53.33%
50-Day Moving Average	0.35
200-Day Moving Average	0.48
Relative Strength Index (RSI)	39.85
Average Volume (20 Days)	1,985

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-356,031
Operating Income	-1.29M
Pretax Income	-3.71M
Net Income	-3.71M
EBITDA	-1.27M
EBIT	-1.29M
Earnings Per Share (EPS)	-0.98

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	13,902
Total Debt	n/a
Net Cash	13,902
Net Cash Per Share	0.00
Equity (Book Value)	-1.48M
Book Value Per Share	-0.23
Working Capital	-1.48M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-499,009
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pangenomic Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-124.44%
Shareholder Yield	-124.44%
Earnings Yield	-464.75%
FCF Yield	n/a

Stock Splits

The last stock split was on November 14, 2024. It was a reverse split with a ratio of 0.2.

Last Split Date	Nov 14, 2024
Split Type	Reverse
Split Ratio	0.2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a